Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis

Overview of attention for article published in Drug Safety, November 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 1 X user

patent: 9 patents

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Composition for treatment of menopause

Grant US-9446086-B2

United States of America

Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae family…

Grant US-9339523-B2

United States of America

Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof

Grant US-9155770-B2

United States of America

Methods of detecting and treatment of cancers using Scutellaria barbata extract

Grant US-8512961-B2

United States of America

Process of making purified extract of Scutellaria barbata D. Don

Grant US-8197868-B2

United States of America

Composition for treatment of menopause

Grant US-8110228-B2

United States of America

Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof

Grant US-8092841-B2

United States of America

Methods and compounds for the targeted delivery of agents to bone for interaction…

Grant US-8071575-B2

United States of America

Scutellaria barbata extract for the treatment of cancer

Grant US-7700136-B2

United States of America